IN RE YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

No. 3:09-md-02100-DRH-PMF.

IN RE: YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION This Document Relates To: All Cases

United States District Court, S.D. Illinois.

August 4, 2014.


Attorney(s) appearing for the Case

In Re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, Plaintiff, represented by Mark R. Niemeyer , Niemeyer, Grebel & Kruse LLC, Michael S. Burg , Burg Simpson Eldridge et al, Michael A. London , Douglas & London PC & Roger C. Denton , Schlichter, Bogard et al..

Bayer Corporation, Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Bayer Healthcare Pharmaceuticals, Inc., Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Bayer Healthcare LLC, Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Walgreen Co., terminated from member cases 09-10012 and 10-20332, Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Bayer AG, Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Bayer Pharmaceuticals Corporation, Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Bayer Schering Pharma AG, Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox, Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Berlex Laboratories, Inc., Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Berlex, Inc., Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.

Barr Laboratories, Defendant, represented by Joseph P. Thomas , Ulmer & Berne LLP.

Teva Pharmaceuticals USA, Inc., Defendant, represented by Joseph P. Thomas , Ulmer & Berne LLP.

Barr Laboratories, Inc., Defendant, represented by Joseph P. Thomas , Ulmer & Berne LLP.

Teva Pharmaceuticals Industries, Ltd., Defendant, represented by Joseph P. Thomas , Ulmer & Berne LLP.

Bayer Pharma AG, also known as Bayer Schering Pharma AG, Defendant, represented by Adam L. Hoeflich , Bartlit, Beck et al., John E. Galvin , Fox Galvin LLC & Terry Lueckenhoff , Fox Galvin, LLC.


CASE MANAGEMENT ORDER NO. 64 Stipulations of Dismissal for Matters Settled Under the Gallbladder Resolution Program

DAVID R. HERNDON, Chief District Judge.

This matter is before the Court for case management. On March 15, 2013, the Court adopted Case Management Order Number 60 ("CMO 60"), which established a settlement resolution program for plaintiffs alleging gallbladder disease and/or gallbladder related injuries resulting from the use of drospirenone...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases